NASDAQ:ASPX (ASPX) (ASPX) Stock Price, News & Analysis → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free ASPX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume1.02 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (ASPX) alerts: Email Address Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. About (ASPX) Stock (NASDAQ:ASPX)Auspex Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for people with movement disorders and other rare diseases, including orphan diseases. Its pipeline includes product candidates to address unmet medical needs in hyperkinetic movement disorders, such as chorea (abnormal involuntary movements) associated with Huntington's disease, an orphan disease, tardive dyskinesia and Tourette syndrome in the pediatric population, which is an orphan disease, as well as other orphan indications. Its lead product candidate is SD-809, which is a small molecule inhibitor of vesicular monoamine transporter 2 (VMAT2). Its other programs include SD-560, SD-1077 and SD-254.Read More Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. ASPX Stock News HeadlinesApril 26, 2024 | msn.comWV Dept. of Health monitoring measles following recent caseApril 26, 2024 | yahoo.comColumbia State hosts spring leadership for Operational Excellence Program receptionApril 26, 2024 | Weiss Ratings (Ad)The Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.April 26, 2024 | finance.yahoo.comBragg Gaming Group to Release First Quarter 2024 Results on May 9April 26, 2024 | msn.comAdvanced insulin pumps enhance blood sugar management in type 1 diabetesApril 26, 2024 | msn.comWhen the NFL draft is over: Steps to take if a flight home will not take off as scheduledApril 26, 2024 | msn.comJNK India IPO allotment status: Check application, latest GMP and listing dateApril 25, 2024 | msn.comNorCal Celtic and California Honey Festivals return to Woodland | Just BusinessApril 26, 2024 | Weiss Ratings (Ad)The Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.April 25, 2024 | msn.comLANE CLOSURES: LA 15 in Monroe, Ouachita Parish, to have ongoing construction on April 29thApril 25, 2024 | tmcnet.comCegedim achieves solid growth in first quarter 2024April 25, 2024 | msn.comPrenatal opioid exposure not associated with risk of neuropsychiatric disorders in childrenApril 25, 2024 | finance.yahoo.comAnnual Report 2023 of Compagnie Financière Tradition SAApril 24, 2024 | msn.comIndian restaurant scores 50 red points. Here are Thurston food safety scores for April 24April 24, 2024 | msn.comSober Living Task Force wants to keep issues in Sacramento’s face as billions are spentApril 24, 2024 | msn.comWhat to know before riding an electric bicycle in Erie, Millcreek or at Presque IsleApril 24, 2024 | finance.yahoo.comNETSCOUT to Report Q4 and Full Fiscal Year 2024 Financial Results on May 9thApril 24, 2024 | msn.comBetter cardiovascular health among middle-aged Black women linked to less decline in cognitionApril 23, 2024 | msn.comOff the Beaten Trail: Navigating summer reservations in ColoradoApril 23, 2024 | msn.comImmune dysfunction mechanism discovered in stroke and heart attack patientsApril 23, 2024 | msn.comInvestigation of missing Texas A&M student enters eighth weekApril 23, 2024 | msn.comMP board result 2024 class 8, class 5 declared: Direct links of official websites - How check on mobile, laptopApril 23, 2024 | msn.comVodafone Idea FPO allotment status: Check application, latest GMP and listing dateApril 23, 2024 | msn.comReview: Facilitators and barriers to vaccination uptake in pregnancyApril 23, 2024 | msn.comBloomfield Township brings back community cleanup eventApril 23, 2024 | msn.comFUJIFILM Healthcare Europe introduces EndoGel training model for endoscopic proceduresApril 22, 2024 | msn.comGoFundMe donations sought for CCPD officer wounded Saturday morningSee More Headlines Receive ASPX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (ASPX) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/16/2015Today4/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:ASPX CUSIPN/A CIK1454189 WebN/A Phone+1-858-5582400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report ASPX Stock Analysis - Frequently Asked Questions How were (ASPX)'s earnings last quarter? (ASPX) (NASDAQ:ASPX) issued its earnings results on Monday, March, 16th. The biopharmaceutical company reported ($0.74) EPS for the quarter, missing the consensus estimate of ($0.59) by $0.15. What other stocks do shareholders of (ASPX) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (ASPX) investors own include Achillion Pharmaceuticals (ACHN), Alnylam Pharmaceuticals (ALNY), GoPro (GPRO), Ambarella (AMBA), Alkermes (ALKS), Align Technology (ALGN), Akebia Therapeutics (AKBA), Agios Pharmaceuticals (AGIO), ACADIA Pharmaceuticals (ACAD) and Arbutus Biopharma (ABUS). This page (NASDAQ:ASPX) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (ASPX) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
